Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.47 |
| ▸ | MEN1 | O00255 | 4/20 | 0.47 |
| ▸ | LMNA | P02545 | 4/20 | 0.47 |
| ▸ | GAA | P10253 | 3/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | PIKFYVE | Q9Y2I7 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | PIK3CA | P42336 | 6/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | PIK3CB | P42338 | 2/20 | 0.44 |
| ▸ | PIK3CG | P48736 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32669196 | 0.85 | MAPT (0.67) | MAPTKMT2AMEN1LMNAGAA | |
| SCHEMBL32669323 | 0.81 | PIKFYVE (0.61) | MAPTKMT2AMEN1LMNAGAA | |
| SCHEMBL32669339 | 0.79 | PIK3CA (0.48) | MAPTKMT2AMEN1LMNAGAA | |
| SCHEMBL32669402 | 0.79 | LMNA (0.49) | MAPTKMT2AMEN1LMNAGAA | |
| SCHEMBL32669211 | 0.77 | MAPT (0.70) | MAPTKMT2AMEN1LMNAGAA | |
| SCHEMBL32669200 | 0.77 | GAA (0.59) | MAPTKMT2AMEN1LMNAGAA | |
| SCHEMBL32669369 | 0.75 | MAPT (0.58) | MAPTKMT2AMEN1LMNAGAA | |
| SCHEMBL1309950 | 0.75 | PIK3CA (0.55) | KMT2AMEN1LMNAGAAPIK3CA | |
| SCHEMBL3325959 | 0.73 | MAPT (0.62) | MAPTKMT2AMEN1LMNAGAA | |
| SCHEMBL3088439 | 0.73 | MAPT (0.62) | MAPTKMT2AMEN1LMNAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260034141-A1 | METHODS AND COMPOSITIONS FOR TREATING MALIGNANT CANCERS | 6J BIOTECHNOLOGY HONG KONG LTD (HK) | 2026-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260034141-A1 | METHODS AND COMPOSITIONS FOR TREATING MALIGNANT CANCERS | MCL1, GLI1, BECN1 | MAPT 538/4885KMT2A 2267/4885MEN1 5/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.